## Core Concept
Sucralfate is a medication used in the treatment of peptic ulcers. Its mechanism of action involves forming a protective barrier over the ulcer site, which protects it from acid and enzymes in the stomach, thereby facilitating healing. The drug works locally in the gastrointestinal tract and has minimal systemic absorption.

## Why the Correct Answer is Right
The correct rationale for sucralfate therapy includes its ability to form a protective barrier over ulcers, its local action in the gastrointestinal tract with minimal systemic absorption, and its effectiveness in healing peptic ulcers by protecting them from acidic gastric contents. Sucralfate does not significantly affect gastric acid secretion.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is not provided, but typically, correct rationales for sucralfate therapy include its protective barrier effect and local action.
- **Option B:** Similarly, this option is missing, but generally, sucralfate's mechanism does not involve systemic effects or significant alteration of gastric pH.
- **Option C:** Without the specific content of option C, it's challenging to address directly, but if it aligns with sucralfate's known mechanisms (like protective barrier formation), it would be a correct rationale.
- **Option D:** This option is stated as the correct answer but without content. Typically, if an option suggests sucralfate works by reducing gastric acid secretion (like a proton pump inhibitor or H2 receptor antagonist), it would be incorrect because sucralfate's primary mechanism does not involve altering acid production.

## Clinical Pearl / High-Yield Fact
A key point to remember is that sucralfate works locally in the gut and does not affect gastric acid production. This is in contrast to other anti-ulcer medications like omeprazole (a proton pump inhibitor) or ranitidine (an H2 receptor antagonist), which decrease acid production. Sucralfate is often chosen for patients with acute kidney injury or those at risk of stress ulcers because it does not require dose adjustment in renal failure and has minimal systemic effects.

## Correct Answer: D.